Modelling the kinetics of hepatitis C virus RNA decline over 4 weeks of treatment with pegylated interferon α-2b

Journal of Viral Hepatitis

Volumn 15, Issue 5, 2008, Pages 379-382

  Shudo, E ^a   Ribeiro, R M ^a   Perelson, A S ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

Hepatitis C virus; Modelling; Pegylated interferon 2b; Pharmacokinetics and pharmacodynamics; Viral kinetics

Indexed keywords

GAMMA INTERFERON; PEGINTERFERON ALPHA2B; VIRUS RNA;

ARTICLE; COMPUTER SIMULATION; DRUG EFFICACY; HEPATITIS C; KINETICS; PRIORITY JOURNAL; VIRION;

ANTIVIRAL AGENTS; COMPUTER SIMULATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MODELS, BIOLOGICAL; RNA, VIRAL; VIRAL LOAD;

EID: 41549151607     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.00977.x     Document Type: Article

References (13)

1. Neumann AU, Lam NP, Dahari H et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998 282 (5386 103 107.
2. Talal AH, Ribeiro RM, Powers KA et al. Pharmacodynamics of PEG-IFN α differentiate HIV/HCV coinfected sustained virological responders from nonresponders. Hepatology 2006 43 (5 943 953.
3. Shudo E, Ribeiro RM, Perelson AS. Modeling hepatitis C virus kinetics during treatment with pegylated interferon a-2b: errors in the estimation of viral kinetic parameters. J Viral Hepat. doi :.
4. Powers KA, Dixit NM, Ribeiro RM, Golia P, Talal AH, Perelson AS. Modeling viral and drug kinetics: hepatitis C virus treatment with pegylated interferon alfa-2b. Semin Liver Dis 2003 23 (Suppl 1 13 18.
5. Buti M, Sanchez-Avila F, Lurie Y et al. Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin. Hepatology 2002 35 (4 930 936.
6. Formann E, Jessner W, Bennett L, Ferenci P. Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1. J Viral Hepat 2003 10 (4 271 276.
7. Lewin SR, Ribeiro RM, Walters T et al. Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed. Hepatology 2001 34 (5 1012 1020.
8. Sherman KE, Shire NJ, Rouster SD et al. Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Gastroenterology 2005 128 (2 313 327.
9. Torriani FJ, Ribeiro RM, Gilbert TL et al. Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection. J Infect Dis 2003 188 (10 1498 1507.
10. Dahari H, Lo A, Ribeiro RM, Perelson AS. Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy. J Theor Biol 2007 247 (2 371 381.
11. Dahari H, Ribeiro RM, Perelson AS. Triphasic decline of hepatitis C virus RNA during antiviral therapy. Hepatology 2007 46 (1 16 21.
12. Herrmann E, Lee JH, Marinos G, Modi M, Zeuzem S. Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon. Hepatology 2003 37 (6 1351 1358.
13. ter Borg M, Hansen G, Herrmann E et al. Modelling of early viral kinetics and pegylated interferon-alpha pharmacokinetics in patients with HBeAg-positive chronic hepatitis B. Antiviral Ther. 2007 12 (8 1285 1294.